PDS-MMAE
PDS-MMAE (Compound 5’) is a modified MMAE (HY-15162) . PDS-MMAE can be used for preparation of neurotensin receptor binding conjugates[1].
Product Specifications
CAS Number
[1613113-44-2]
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pds-mmae.html
Purity
99.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H](C(N[C@H](C)[C@H](C1=CC=CC=C1)O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCCSSC3=CC=CC=N3)=O)=O)=O)=O)OC
Molecular Formula
C47H74N6O9S2
Molecular Weight
931.26
References & Citations
[1]Mark T. Bilodeau, et al. Neurotensin receptor binding conjugates and formulations thereof. Patent. WO2017180834.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1393689-05 0.02 mg (Baculovirus)
Recombinant Vibrio vulnificus Protein sprT (sprT)
Ask
View Details